Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy
Journal of Pharmaceutical Analysis · 2026-10 · 16 (10) · 101672
DOI: 10.1016/j.jpha.2026.101672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-10. Verfasst von Chongyang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Resource Insects, Medical Research Institute, Southwest University, Chongqing, 400716, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Major Project of Guangxi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Resource Insects, Medical Research Institute, Southwest University, Chongqing, 400716, China.
- Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
- Jinfeng Laboratory, Chongqing, 400715, China.
- Department of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
- Science and Technology Major Project of Guangxi
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hebei Province
Zitieren
APA
Li, C., Xu, M., Ji, Y., Deng, C., Wan, S., Ding, X., Zhang, K., Zhao, E., Pan, G., Hu, X., Li, C., Ji, H., Hu, X., Shi, S., & Cui, H. (2026). Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy. Journal of Pharmaceutical Analysis, 16(10), 101672. https://doi.org/10.1016/j.jpha.2026.101672
Vancouver
Li C, Xu M, Ji Y, Deng C, Wan S, Ding X, et al. Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy. Journal of Pharmaceutical Analysis. 2026;16(10):101672. doi:10.1016/j.jpha.2026.101672
BibTeX
@article{Li2026,
author = {Li, Chongyang and Xu, Minghao and Ji, Yacong and Deng, Chaowei and Wan, Sicheng and Ding, Xiangfei and Zhang, Kui and Zhao, Erhu and Pan, Guangzhao and Hu, Xin and Li, Changhong and Ji, Haoyan and Hu, Xiaosong and Shi, Shaomin and Cui, Hongjuan},
title = {Cyclovirobuxine D suppresses gastric cancer growth by targeting the V-ATPase complex and inducing excessive endo-lysophagy},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
volume = {16},
number = {10},
pages = {101672},
doi = {10.1016/j.jpha.2026.101672}
}
EUVIMED